Inactive Instrument
Deltagen Inc. Stock Other OTC
Stocks
DGEN
US24783R1032
Pharmaceuticals
OTC Markets Traded| Market Cap | 4.71M 4.2M 3.91M 3.56M 6.72M 456M 6.74M 47.06M 18.44M 232M 17.68M 17.29M 745M | P/E 2005 * |
-
| P/E 2006 | 4.04x |
|---|---|---|---|---|---|
| Enterprise Value | -1.43M -1.28M -1.19M -1.08M -2.04M -138M -2.05M -14.28M -5.6M -70.47M -5.36M -5.25M -226M | EV / Sales 2005 * |
-
| EV / Sales 2006 | 1.16x |
| Free-Float |
100% | Yield 2005 * |
-
| Yield 2006 | - |
| 1 day | +154.90% |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Driscoll
CEO | Chief Executive Officer | - | 01/01/2005 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +154.90% | +154.90% | - | - | 32 | |
| +0.83% | +3.19% | +37.87% | +106.25% | 1,051B | |
| +1.93% | +2.11% | +36.82% | +64.90% | 630B | |
| +1.49% | +5.19% | +19.84% | +85.41% | 489B | |
| +2.26% | +0.90% | +66.40% | +39.33% | 359B | |
| +1.45% | +3.50% | +21.87% | +42.64% | 344B | |
| +1.17% | +2.37% | +11.71% | +35.14% | 272B | |
| +0.89% | +1.08% | -7.28% | +10.52% | 246B | |
| +1.82% | +2.94% | +40.43% | +52.78% | 224B | |
| +2.77% | +4.44% | +29.49% | +101.40% | 187B | |
| Average | +16.84% | +2.53% | +28.57% | +59.82% | 422.63B | |
| Weighted average by Cap. | +1.20% | +2.44% | +31.57% | +69.97% |
| 2002 | 2003 * | |
|---|---|---|
| Net sales | 17.69M 15.8M 14.7M 13.37M 25.24M 1.71B 25.35M 177M 69.31M 873M 66.43M 64.98M 2.8B | - |
| Net income | -107M -95.71M -89.04M -80.99M -153M -10.37B -154M -1.07B -420M -5.29B -402M -394M -16.97B | - |
| Net Debt | 1.75M 1.56M 1.45M 1.32M 2.49M 169M 2.5M 17.47M 6.84M 86.2M 6.56M 6.42M 277M | - |
Employees
-
Sector
Pharmaceuticals
